Unlock Premium Data: Up to 50% Off InvestingProCLAIM SALE

SHL Telemedicine in talks with Discount Capital

EditorIsmeta Mujdragic
Published 06/20/2024, 07:41 AM
SHLT
-

TEL AVIV - SHL Telemedicine Ltd. (NASDAQ: SHLT, SIX: SHLTN), a provider of advanced personal telemedicine solutions, disclosed today that it is in preliminary discussions with Discount Capital Ltd., the investment arm of Israel Discount Bank, concerning a potential investment in SHL's operations in Israel. The company emphasized that no decisions have been made and no binding agreements are in place regarding the potential transaction.

SHL Telemedicine specializes in the development and marketing of personal telemedicine systems, as well as offering medical call center services. The company focuses primarily on cardiovascular and related diseases, providing its telemedicine devices and services to subscribers through telephone and internet communication technologies.

Despite the public announcement, it is important to note that discussions are at an exploratory stage. Both SHL and Discount Capital have yet to reach any formal decision or enter into any obligations that would commit to the investment. SHL has committed to keeping the market updated as necessary regarding the progression of these discussions.

This news comes as telemedicine continues to gain traction globally as a means to provide healthcare services, especially in the context of managing chronic conditions such as heart disease. SHL's engagement in this sector positions it within a growing market that leverages technology for healthcare delivery.

This report is based on a press release statement from SHL Telemedicine.

InvestingPro Insights

In light of SHL Telemedicine Ltd.'s ongoing discussions with Discount Capital Ltd. for a potential investment, a deeper look into the company's financial health and market performance is warranted. According to InvestingPro data, SHL Telemedicine holds a market capitalization of $85.28 million. While the company's revenue for the last twelve months as of Q4 2023 stood at $57.08 million, it has experienced a slight decline in revenue growth during the same period, with a -3.26% change year-over-year. This indicates a challenging market environment or operational headwinds that the company might be facing.

From an investment standpoint, two InvestingPro Tips provide a mixed outlook. On the positive side, SHL Telemedicine operates with a moderate level of debt and has liquid assets that exceed its short-term obligations, suggesting a degree of financial stability. However, the company has not been profitable over the last twelve months, and it does not pay a dividend to shareholders, which may influence the investment considerations of income-focused investors.

For those seeking a comprehensive analysis, InvestingPro offers additional tips, which could provide further insights into SHL Telemedicine's financial position and future outlook. Subscribers can benefit from these insights by using the coupon code PRONEWS24 to get an additional 10% off a yearly or biyearly Pro and Pro+ subscription. With several more tips available on InvestingPro, investors can gain a more nuanced understanding of the company's potential and make informed decisions.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.